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Abstract Bone cells respond to mechanical stimulation via me-
chanoreceptors and convert biophysical stimulation into bio-
chemical signals that alter gene expression and cellular adap-
tation. Pulsed acoustic energy treatment raises membrane
potential and induces osteogenic activity. How membrane-bound
osteoblast mechanoreceptors convert physical ultrasound (US)
stimuli into osteogenic responses is not fully understood. We
demonstrated that low-intensity pulsed US treatment (200-Ws
pulse, 1 kHz, 30 mW/cm2) elevated Cbfa1/Runx2 mRNA ex-
pression and progressively promoted osteocalcin mRNA expres-
sion in human osteoblasts. Pretreatment with pertussis toxin
(PTX), but not with cholera toxin, suppressed US-augmented
osteogenic transcription. This indicated that Gi proteins, but not
Gs proteins, were involved in US promotion of osteogenic tran-
scription. Further studies demonstrated US treatment could rap-
idly increase PTX-sensitive GKi protein levels and subsequently
enhanced phosphorylation of extracellular signal-regulated ki-
nase (ERK). PTX pretreatment signi¢cantly reduced US pro-
motion of ERK activation. Moreover, inhibition of ERK activity
by PD98059 suppressed US augmentation of Cbfa1/Runx2 and
osteocalcin mRNA expression. Membranous GKi proteins and
cytosolic ERK pathways acted as potent mechanosensitive sig-
nals in the response of osteoblasts to pulsed US stimulation.
: 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Bone cells perceive and respond to mechanical force via a
mechanotransduction mechanism. Mechanoreceptors convert
biophysical stimuli into biochemical responses that alter gene
expression and cellular adaptation [1]. Mechanical interven-
tion can elicit a proliferative response from bone cells. Be-
cause mechanical adaptive modeling response promotes
bone tissue formation in fracture healing [2^4], extracorporeal
shock waves, mechanical distraction and electromagnetic
¢elds are regarded as non-invasive strategies for bone repair
[5^7].
The acoustic energy of non-invasive, low-intensity pulsed
ultrasound (US) has been shown to accelerate fracture healing
[8^10]. US raises osteogenic responses of osteoblasts through
induction of prostaglandin E2 and osteogenic factors [11^13].
The role played by osteoblast mechanoreceptors in mediating
physical US stimuli requires further study. Research has
postulated that increasing current across the cell membrane
by pulsed stimulation facilitates tissue regeneration [14,15].
Cell membrane hyperpolarization is induced by mechanical
strain and pulsed acoustic energy [16,17]. This implies that
membrane perturbation potentially provokes membrane-
bound signaling transduction, which in turn activates a cas-
cade of osteogenic activity.
Guanine nucleotide regulatory proteins (G proteins) are a
family of GTP-binding proteins that mediate signal transduc-
tion. Previous studies have demonstrated that G proteins were
involved in strain-activated proliferation of human endothelial
cells [18]. These molecules mediated steady/transient £uid
shear stress-stimulated nitric oxide production [19,20], and
£ow-induced prostaglandin E2 production by osteoblasts
[21]. Extracellular signal-regulated kinase (ERK), a member
of the mitogen-activated protein kinase family, mediated the
transduction of mechanical stimulation into intracellular sig-
nals that regulate cell proliferation and di¡erentiation [23,24].
We hypothesized that US promotes osteogenic activity
through activation of membrane-bound G protein ERK.
The purposes of this study were to examine the e¡ect of US
on the osteogenic responses of human osteoblasts and to in-
vestigate whether US promotion of osteogenic activity is
linked to activation of G proteins and ERK.
2. Materials and methods
2.1. Cell culture
Human fetal preosteoblastic cells (CRL-11372, American Type Cul-
ture Center, Manassas, VA, USA) were maintained in a mixture of
phenol red-free Ham’s F12 medium and Dulbecco’s modi¢ed Eagle’s
medium (1:1) containing 10% fetal bovine serum and 2.5 mM L-glu-
tamine (Life Technologies, Gaithersburg, MD, USA) in a 5% CO2,
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34‡C incubator for 6 days. Cells were harvested by trypsinization and
resuspended in medium for studies.
2.2. Ultrasound treatment
Cells (5U105 cells/well, 6-well plate) were cultured for 48 h and
were subjected to US with modi¢cations as previously described
[22]. Culture plates were £oated in a thermostatically controlled water
bath. A UV-sterilized transducer (Sonic Accelerated Fracture Healing
System; Exogene, USA) that generated 1.5 MHz US in a pulsed-wave
mode (200-Ws pulse burst width with repetition frequency of 1 kHz at
the intensity of 30 mW/cm2) was immersed vertically into each culture
well and placed to just touch the surface of the medium. The distance
between the transducer and the cells was approximately 5^6 mm.
Exposure time was 20 min for all cultures. Control samples were
prepared in the same manner except that they were not exposed to
US. Cells were harvested 30 min, 1, 3, 6, and 12 h after US treatment.
To investigate the role of G protein in US promotion of osteogenic
transcription, subcon£uent cell cultures were pretreated with 2 ng/ml
pertussis toxin (PTX) or cholera toxin (CTX; Sigma Chemicals, St.
Louis, MO, USA) to block the G protein pathway for 24 h prior to
US treatment. In some experiments, subcon£uent cell cultures were
pretreated with 20 WM PD98059 (Calbiochem, La Jolla, CA, USA) to
inhibit ERK activity for 4 h before US treatment.
2.3. Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted and puri¢ed by the Tri reagent contain-
ing a monophasic solution of guanidine thiocyanate and phenol (Sig-
ma Chemicals) from 106 cells with and without US treatment. One
microgram of total RNA was reversely transcribed into cDNA, fol-
lowed by PCR ampli¢cation using the following human gene-speci¢c
primers: Cbfa1/Runx2 (forward, 5P-GAA TGC TTC ATT CGC CTC
ACA-3P ; reverse, 5P-TGA CCT GCG GAG ATT AAC CAT-3P) (114-
bp product expected); osteocalcin (forward, 5P-AAG AGA CCA
AGG CGC TAC CT-3P ; reverse, 5P-GCC GAT AGG CCT CCT
TGA AAG-3P) (135-bp product expected); L-actin (forward, 5P-
CGC CAA CCG CGA GAA GAT-3P ; reverse, 5P-CGT CAC CGG
AGT CCA TCA-3P) (168-bp product expected). The parameters for
RT-PCR cycling were set as follows: RT reaction at 50‡C for 2 min
and at 60‡C for 30 min; and PCR reaction at 95‡C for 5 min; fol-
lowed by 40 cycles of 94‡C for 20 s and 60‡C for 1 min. The PCR
products were run on a 1.5% agarose gel electrophoresis containing
ethidium bromide and visualized with UV-induced £uorescence. All
signals were quanti¢ed by scan densitometry and the ¢nal value was
obtained by calculating the Cbfa1/L-actin and osteocalcin/L-actin ra-
tio values. The fold of promotion was calculated as the increase over
the value of its corresponding control sample.
2.4. Preparation of membranous and cytosolic extracts
Membranous and cytosolic proteins of cell cultures were harvested
as previously described [17]. Brie£y, cells were lysed with ice-cold
bu¡er C containing 10 mM Tris^HCl (pH 7.9), 10 mM KCl, 2 mM
MgCl2, 0.1 mM EDTA and 0.7% NP-40 on ice for 10 min and then
centrifuged at 500Ug for 5 min. Pellets were further lysed with bu¡er
A containing 40 mM Tris^HCl (pH 7.9), 350 mM NaCl, 2 mM
MgCl2, 1 mM EDTA, 0.2 mM EGTA, 20% glycerol, 1% NP-40,
1 mM phenylmethylsulfonyl £uoride, 2 WM dithiothreitol (DTT),
2 Wg/ml leupeptin and 1 Wg/ml aprotinin on ice for 20 min and cen-
trifuged at 12 000Ug, at 4‡C for 10 min. Pellets were dissolved in
bu¡er A and protein concentrations of extracts were determined by
a Bio-Rad assay kit (Bio-Rad Laboratories, Hercules, CA, USA).
2.5. ADP-ribosylation
ADP-ribosylation of membranous protein was determined as pre-
viously described [25]. 40 Wg of membranous protein was incubated
for 30 min at 25‡C with 10 mM thymidine, 1 mM ATP, 0.1 mM GTP,
25 mM [Q-32P]NAD (10 Ci/mmol; Amersham Life Sciences, Ayles-
bury, UK), 2 mM MgCl2, 20 mM ADP-ribose and 20 Wg/ml PTX
(pre-activated with 10 WM DTT for 30 min at 32‡C; Sigma Chem-
icals). The reaction was terminated by addition of 10 mM Tris^
EDTA, 1 mM EDTA, and 50 mM K2PO4 (pH 8.0) and the mem-
branous proteins were harvested by centrifugation at 16 000Ug for 10
min at 4‡C. Membranous proteins were dissolved in Laemmli bu¡er
containing 200 mM Tris^HCl (pH 6.8), 10% glycerol, 4% SDS, 50 WM
DTT and 0.05% bromophenol blue for 5 min at 95‡C, and separated
by electrophoresis through 12% polyacrylamide gels. Gels were then
electrotransferred onto polyvinylidene di£uoride (PVDF) membranes
(Hoefer Pharmacia Biotech, CA, USA). Following transfer, mem-
branes were rinsed, air-dried and autoradiographed with an intensify-
ing screen. GKi-1/3, GKi-2 and GKs proteins on the membranes were
further recognized by speci¢c mouse anti-GKi-1/3, anti-GKi-2 and
anti-GKs antibodies (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), followed by goat anti-mouse horseradish peroxidase-conju-
gated IgG as the second antibody. Bands were visualized using chemi-
luminescence agents (SuperSignal0 ; Pierce, Rockford, IL, USA).
Autoradiographs and Western blots from the same PVDF membranes
were then aligned for band comparison and identi¢cation.
2.6. Measurement of ERK activation
Cytosolic extracts were incubated with anti-ERK antibody (Upstate
Biotechnology, Lake Placid, NY, USA) for 1 h at 4‡C. After incuba-
tion, immune complexes were precipitated with protein A (Sigma
Chemicals) [26]. ERK activation was measured with an in vitro
ERK phosphorylation kit (Upstate Biotechnology) according to the
manufacturer’s instructions. Brie£y, the ERK immunoprecipitate (20
Wg) reacted with substrate bu¡er containing 20 Wg myelin basic pro-
tein (MBP), 15 mM MgCl2, 100 WM ATP and 5 WM protein kinase
inhibitor for 30 min at 30‡C. The reaction was stopped with Laemmli
bu¡er for 5 min at 95‡C. Mixtures were subjected to Western blot
assay. Phosphorylated MBP on the blot was recognized by a speci¢c
mouse anti-phospho-MBP antibody, followed by goat anti-mouse
horseradish peroxidase-conjugated IgG as the second antibody. The
ERK activity was indicated by phosphorylated MBP detected by
chemiluminescence agents [26].
2.7. Statistical analysis
All values were analyzed; Student’s paired t-test was used to eval-
uate the di¡erence between the sample of interest and its respective
control. For time course analysis, multiple ANOVA was used. A
P value of 6 0.05 was considered signi¢cant.
3. Results
3.1. US treatment increased Cbfa1/Runx2 and osteocalcin
mRNA expression
We ¢rst determined whether US augmented Cbfa1/Runx2
and osteocalcin gene expression in osteoblasts. Cell cultures
were treated with US for 20 min. RT-PCR results indicated
that Cbfa1/Runx2 mRNA expression signi¢cantly increased
within 1 h and 12 h after treatment, peaking at 3 h (Fig. 1).
Similarly, osteocalcin mRNA expression of cell culture was
signi¢cantly elevated 6 h after US treatment (Fig. 1).
3.2. Pretreatment with PTX, but not with CTX, reduced US
promotion of osteogenic transcription
To determine whether the G protein pathway was involved
in US promotion of Cbfa1/Runx2 and osteocalcin transcrip-
tion, cell cultures were pretreated with PTX or with CTX to
Fig. 1. Low-intensity pulsed US treatment promoted Cbfa1/Runx2
mRNA expression and subsequently increased osteocalcin mRNA
expression. Human osteoblasts (5U105 cells/well, 6-well plate) were
treated with 1.5 MHz US (200-Ws pulse, 1 kHz, 30 mW/cm2) for 20
min. Cells were subjected to assessment of Cbfa1/Runx2 and osteo-
calcin mRNA 0, 1, 3, 6 and 12 h after US treatment. After stan-
dardization of housekeeping gene expression, equal amounts of
cDNA from each sample were subjected to 40 cycles of PCR to am-
plify Cbfa1/Runx2 and osteocalcin mRNA expressions.
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block Gi or Gs protein activity. PTX pretreatment signi¢-
cantly reduced US-promoted Cbfa1/Runx2 mRNA expression
in 3 h and osteocalcin mRNA expression in 6 h (Fig. 2). CTX
pretreatment did not signi¢cantly alter US promotion of
Cbfa1/Runx2 and osteocalcin mRNA expression (Fig. 2).
This indicated that Gi proteins were involved in physical US
promotion of osteogenic transcription.
3.3. US treatment increased PTX-sensitive GKi protein levels
and ERK phosphorylation
In vitro ADP-ribosylation was used to determine whether
US increased PTX-sensitive Gi protein levels in osteoblasts.
Membrane proteins were prepared and were subjected to
ADP-ribosylation assay in the presence of [Q-32P]NAD and
activated PTX. Autoradiographs showed that US treatment
signi¢cantly increased levels of PTX-sensitive 41-kDa mole-
cules, but not of 46-kDa or 40-kDa molecules (Fig. 3A, left
panel). We identi¢ed GKi protein subunits and GKs proteins
by overlay and alignment of autoradiographs and Western
blots from the same PVDF membranes. The 41-kDa, 40-
kDa, and 46-kDa bands corresponded to GKi-1/3, GKi-2
(Fig. 3A, middle panels) and GKs proteins (Fig. 3A, right
panel), respectively. Our observation agrees with typical pub-
lished values [18,25]. Kinetic changes in PTX-sensitive GKi
protein levels in US-treated osteoblasts are shown in Fig.
3B. PTX-sensitive GKi protein levels were signi¢cantly in-
creased within 30 min and 6 h after US treatment. Experi-
ments were next carried out to determine which GKi protein
subunit (GKi-1, GKi-2 and GKi-3) was involved in US-aug-
mented PTX-sensitive GKi proteins. Immunoblotting showed
that osteoblasts subjected to US treatment had elevated GKi-
1/3 protein levels, which corresponded to the 41-kDa band.
US stimulation did not alter GKi-2 protein levels throughout
the study period (Fig. 3C). Our recent study has demonstrated
that acoustic energy stimulates ERK-dependent osteogenic
di¡erentiation of bone marrow mesenchymal cells in rats
[26]. We investigated whether US stimulation could increase
ERK phosphorylation of human osteoblasts. ERK immuno-
precipitates harvested from cytosolic proteins were subjected
to kinase activity assay using MBP as a substrate. Phosphor-
Fig. 2. Pretreatment with PTX, but not with CTX, signi¢cantly re-
duced US promotion of Cbfa1/Runx2 and osteocalcin mRNA ex-
pression. Osteoblasts were pretreated with or without 2 ng/ml PTX
or CTX and subjected to US stimulation for 20 min. Expression of
Cbfa1/Runx2 and osteocalcin mRNA was determined 3 and 6 h
after US treatment, respectively.
Fig. 3. Increase of membranous PTX-sensitive GKi protein levels and activation of cytosolic ERK. A: US increased levels of PTX-sensitive 41-
kDa molecules, but not 40-kDa or 46-kDa molecules (left panel). The 41-kDa, 40-kDa and 46-kDa molecules corresponded to GKi-1/3, GKi-2
(middle panels) and GKs proteins (right panel), respectively. Membranous proteins were PTX catalyzed ADP-ribosylation in the presence of [Q-
32P]NAD. Reaction products were separated by SDS^PAGE. Gels were electrotransferred onto PVDF membranes. Membranes were subjected
to autoradiography. GKi-1/3, GKi-2 and GKs proteins on the same membranes were probed by anti-GKi-1/3, anti-GK-2 and anti-GKs antibodies
and were visualized using chemiluminescence agents. B: US enhanced PTX-sensitive GKi protein levels in 30 min. C: US elevated GKi-1/3 pro-
tein levels in 30 min. US did not alter GKi-2 protein expression throughout the study period. Immunoblotting of actin showed equal loading
and transfer for all lanes. D: US progressively increased cytosolic ERK phosphorylation in 1 h. In vitro assay of phosphorylated MBP was
used to measured phosphorylation of cytosolic ERK immunoprecipitate. Immunoblotting of ERK showed equal loading and transfer for all
lanes.
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ylated MBP immunoblotting indicated that US subsequently
increased cytosolic ERK activation in 1 h (Fig. 3D).
3.4. Pretreatment with PTX and with PD98059 blocked
US-augmented ERK activation
We elucidated the role of GKi proteins and ERK in the US
promotion of osteogenic transcription. PTX pretreatment de-
creased US-augmented ERK phosphorylation. PD98059 pre-
treatment blocked US-stimulated ERK activity (Fig. 4A).
PTX inhibition of GKi protein and PD98059 blockade
of ERK activity downregulated US-promoted Cbfa1/Runx2
and osteocalcin mRNA expression (Fig. 4B). These results
suggest that GKi proteins have an important role in mediat-
ing ERK-dependent US enhancement of osteogenic transcrip-
tion.
4. Discussion
Elevation of osteogenic transcription followed pulsed US
treatment that activated membrane-bound GKi protein and
cytosolic ERK. While a number of studies have suggested
that US promotes proliferation and di¡erentiation of osteo-
genic cells [11,12,27], little has been done to de¢ne the role of
G proteins in mediating physical US stimuli. Our ¢ndings
provide the ¢rst indication that the GKi proteinCERKCCb-
fa1/Runx2Costeocalcin pathway is involved in US promo-
tion of osteogenic transcription. Raising US-sensitive signal
transduction and osteogenic transcription of osteoblasts is
proposed as a further explanation for the clinical success of
US treatment on promotion of fracture healing.
Runt domain-related Cbfa1/Runx2 is a critical component
in bone formation and an important transcriptional regulator
in osteoblasts [28]. Activation of Cbfa1/Runx2 increases os-
teocalcin and collagen I gene expression [29,30]. This molecule
is also a target of a mechanical signal by which physical stim-
ulation dictates the cellular and metabolic activities of osteo-
blasts [31]. In this study, we have demonstrated that osteo-
blasts respond to US treatment by increasing Cbfa1/Runx2
and osteocalcin mRNA expression. This suggests that osteo-
blasts convert physical US stimuli into biological responses
that increase osteogenic transcription. Our ¢ndings provide
prominent molecular evidence that explains US-promoted os-
teogenic di¡erentiation of osteoblasts and mesenchymal stem
cells.
The mechanisms underlying US-augmented mechanotrans-
duction of osteogenic activity in osteoblasts are not well
understood. In our study, we provide the ¢rst evidence that
US stimulation increases PTX-sensitive GKi protein levels.
GKi-1/3 proteins are, at least in part, involved in US-aug-
mented osteogenic activity. Previous studies have reported
that G proteins act as potential mitogenic regulators of ¢bro-
blasts [32,33]. G protein activation has been found to be in-
volved in catecholamine- and £uoroaluminate-stimulated al-
kaline phosphatase activity and proliferation of osteoblasts
[34,35]. In the current study, we found that PTX suppressed
US-stimulated osteogenic transcription, indicating that GKi
proteins mediate the e¡ects of physical US stimuli by acting
as potent mechanoreceptors for osteoblasts. It is not presently
known by which mechanisms US activates GKi proteins in
osteoblasts. A previous study has postulated that pulsed stim-
ulation by US raises current across the cell membrane to in-
crease anabolic responses in cells [36]. We have previously
reported that pulsed acoustic energy induces membrane hy-
perpolarization of osteogenic cells [17], implying that altera-
tion of membrane potential may activate membrane-bound Gi
proteins. Physical stimulation of membrane perturbation has
been reported to activate mechanosensitive molecules such as
ion channels and integrins [37,38]. These bio-active molecules
are probably involved in activating GKi proteins in osteo-
blasts after US stimulation.
We also found that US treatment rapidly increased mem-
brane-bound GKi protein activation and subsequently trans-
duced stimuli to activate cytosolic ERK. Previous studies have
demonstrated that ERK plays a critical role in regulating £uid
movement-stimulated osteoblast proliferation [39]. Gi proteins
are involved in ERK activation in growth factor-stimulated
osteoblast proliferation [40]. Our research further indicates
that PD98059 inhibition of ERK signi¢cantly reduces US-
augmented osteogenic transcription, suggesting osteoblasts
convert pulsed acoustic energy into osteogenic signals via
ERK activation. These ¢ndings agree with those in our pre-
vious studies, which demonstrated that bone marrow mesen-
chymal stem cells responded to pulsed acoustic energy by
increasing ERK phosphorylation and enhancing osteogenic
Fig. 4. E¡ects of PTX and PD98059 on ERK activation and osteogenic transcription of US-treated osteoblasts. A: Pretreatment with PTX and
with PD98059 (PD) suppressed US promotion of ERK phosphorylation. In vitro assay of phosphorylated MBP was used to measure cytosolic
ERK phosphorylation. B: PTX and PD98059 signi¢cantly reduced Cbfa1/Runx2 and osteocalcin mRNA expression as determined by RT-PCR.
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di¡erentiation [17,26]. Moreover, intracellular signals that
promote osteoblast growth and di¡erentiation, including
those mediated by bio-active radicals such as nitric oxide,
prostaglandins and calcium, may occur in response to cellular
homeostatic disturbance induced by US [11^13,22]. These
data indicate that multiple signal transduction pathways are
responsible for US-promoted osteogenic activity of osteo-
blasts. Mesenchymal stem cells including osteogenic precursor
cells and perivascular progenitor cells have the potential to
di¡erentiate into bone-forming cells [41^43]. Nevertheless,
we cannot exclude the possibility that pericytes in mesenchy-
mal stem cells contribute to the US promotion of osteogene-
sis. Future studies need to evaluate what roles these molecules
and cell populations play in the regulation of osteogenic tran-
scription by osteogenic cells in response to pulsed US treat-
ment.
In summary, pulsed US treatment rapidly activated mem-
brane-bound GKi protein and cytosolic ERK. These mole-
cules play an essential role in regulating US-promoted osteo-
genic transcription of osteoblasts. Physical US treatment
provides a promising regimen for regulating osteogenic activ-
ity. US stimulation may not only be applicable for enhancing
osteogenesis but also provide an alternative non-invasive
method for ex vivo extension of mesenchymal stem cells and
tissue regeneration in the future.
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